Viewing Study NCT05243550

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 5:08 PM

Ignite Modification Date: 2026-01-01 @ 8:31 AM

Study NCT ID: NCT05243550

Status: ACTIVE_NOT_RECRUITING

Last Update Posted: 2024-11-04

First Post: 2022-02-07

Is Gene Therapy: True

Has Adverse Events: True

Brief Title: A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Sponsor: UroGen Pharma Ltd.

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module Adverse Events Module Baseline Characteristics Module Participant Flow Module